Part the First: If You Stretch Biomedical Science Too Far It Breaks, Every Time.  Gene editing using CRISPR technology has made possible great leaps in biomedical science, and Emanuelle Charpentier and Jennifer Doudna were rightly awarded a Nobel Prize in Chemistry for it in 2020.  The prospects for CRISPR in therapy for tractable genetic diseases are unlimited.  But it must be used with great care and good sense.  Then there is this: Once again, a child dies in gene-editing trial in China, rekindling debate on transparency and safety (HuidaGene, under loosened oversight, was testing CRISPR therapy in a boy with...